United States · FDA National Drug Code directory
cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-547_662007e2-462e-4513-b5b0-efd5dcdc2421
- Product NDC
- 67877-547
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- cefdinir
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210220
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFDINIR — 125 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 100 mL in 1 BOTTLE (67877-547-88) · 67877-547-88
- 60 mL in 1 BOTTLE (67877-547-98) · 67877-547-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →